Hydrochlorothiazide (HCTZ) is a thiazide “water pill” widely used to treat high blood pressure and fluid retention (edema) related to heart failure, liver disease, or kidney disorders. By helping your kidneys remove excess salt and water, it lowers blood pressure, reduces swelling, and decreases strain on the heart and blood vessels. It’s typically taken once daily, is generally well tolerated, and has decades of real‑world use. Like all medications, HCTZ can cause side effects and drug interactions, and it requires monitoring of electrolytes and kidney function. In the U.S., it is prescription-only; avoid sites promising it without medical oversight.
Hydrochlorothiazide is a first-line thiazide diuretic used to treat primary hypertension (high blood pressure) in adults and, in select cases, adolescents. By reducing blood volume and, over time, lowering peripheral vascular resistance, HCTZ helps decrease the risk of heart attack, stroke, and kidney damage when used as part of a long-term cardiovascular risk management plan.
Beyond blood pressure control, HCTZ relieves edema caused by congestive heart failure, chronic venous insufficiency, hepatic cirrhosis, nephrotic syndrome, and certain medications (such as steroids). Reducing excess fluid can ease shortness of breath, leg swelling, and abdominal bloating, improving day-to-day comfort and mobility.
Clinicians often prescribe HCTZ alone for mild hypertension or pair it with other antihypertensives like ACE inhibitors, ARBs, beta-blockers, or calcium channel blockers when blood pressure goals are not reached with monotherapy. Combination tablets (e.g., lisinopril/HCTZ, losartan/HCTZ) simplify regimens and can improve adherence.
Because hydrochlorothiazide is generally affordable and effective, it’s commonly chosen for long-term management. However, it is not intended for emergency situations such as hypertensive crises or acute pulmonary edema, which require urgent medical care.
For hypertension, typical adult starting doses are 12.5–25 mg once daily, taken in the morning to minimize nighttime urination. Many patients reach target blood pressure with 25 mg daily. Some may require 50 mg daily, but higher doses increase the risk of side effects without proportionally greater benefit. Your clinician will individualize the dose based on blood pressure response, kidney function, and any coexisting conditions.
For edema, dosing often begins at 25–50 mg once daily, with adjustments up to 100 mg daily in single or divided doses under medical supervision. When used with loop diuretics (e.g., furosemide) for resistant edema, close monitoring of electrolytes is essential because combined diuresis increases the risk of dehydration and electrolyte disturbances.
Take hydrochlorothiazide at the same time each day with a glass of water. It can be taken with or without food. Because the diuretic effect typically starts within 2 hours (peaks around 4–6 hours and can last 6–12 hours), morning dosing is preferred to avoid nocturia. Do not adjust your dose without guidance; periodic monitoring of blood pressure, kidney function, and electrolytes (sodium, potassium, magnesium) is standard.
HCTZ is less effective when kidney function is significantly reduced (e.g., estimated GFR below ~30 mL/min/1.73 m²). In such cases, a loop diuretic may be considered. Older adults and those with liver disease may need lower doses and slower titration. Always follow the plan established by your prescriber.
Electrolytes: Hydrochlorothiazide can lower potassium, sodium, and magnesium and raise calcium and uric acid. Low potassium can cause muscle cramps, weakness, or heart rhythm changes; low sodium can cause confusion, headache, or seizures. Your clinician may recommend periodic blood tests and, if needed, potassium supplementation or a diet rich in potassium (unless contraindicated).
Kidney and liver considerations: HCTZ relies on kidney function to work and can worsen dehydration-related kidney injury if overdiuresis occurs. In cirrhosis, overly aggressive diuresis increases the risk of electrolyte imbalances and hepatic encephalopathy, requiring careful dosing and monitoring.
Metabolic effects: Thiazides can modestly increase blood sugar and cholesterol/triglycerides. People with diabetes may need adjustments to antidiabetic therapy and closer glucose monitoring, especially when starting or changing the dose.
Gout and uric acid: HCTZ can raise uric acid and trigger gout flares. If you have a history of gout, discuss preventive strategies with your clinician.
Sun sensitivity and skin: Hydrochlorothiazide can increase photosensitivity. Use sunscreen, wear protective clothing, and limit peak sun exposure. Rarely, thiazides have been associated with non-melanoma skin cancer after long-term, high cumulative exposure; regular skin checks and sun safety are prudent.
Eye effects: Very rarely, sulfonamide-derived drugs (including HCTZ) can precipitate acute angle-closure glaucoma and transient myopia. Seek urgent care for sudden eye pain or vision changes.
Allergy: Do not use if you’ve had a serious hypersensitivity reaction to hydrochlorothiazide or other sulfonamide-derived drugs. Mild sulfa antibiotic allergy does not always predict reaction to thiazides, but caution is advised.
Pregnancy and breastfeeding: Thiazides are not first-line for hypertension in pregnancy and should generally be avoided unless benefits clearly outweigh risks. They cross the placenta and, at higher doses, may reduce maternal plasma volume. Small amounts enter breast milk; low doses may be compatible with breastfeeding, but high doses can reduce milk supply. Discuss options with your obstetrician or pediatrician.
Hydration and alcohol: Dehydration amplifies side effects. Maintain adequate fluid intake, especially in hot weather. Alcohol can heighten dizziness and low blood pressure—use cautiously.
Do not take hydrochlorothiazide if you have anuria (inability to make urine) or a known severe allergy to HCTZ or other sulfonamide-derived medications. Concomitant use with dofetilide is contraindicated due to a risk of dangerous heart rhythm disturbances from elevated dofetilide concentrations.
Use is generally not appropriate in severe renal impairment where thiazides are ineffective. Caution is required in advanced liver disease, gout, significant electrolyte abnormalities, and in combination with other medications that affect electrolytes or blood pressure.
Common effects: Increased urination, mild dizziness or lightheadedness (especially when standing up quickly), dry mouth, thirst, and muscle cramps. These often improve as your body adjusts or with small dose changes.
Electrolyte-related: Low potassium (hypokalemia), low sodium (hyponatremia), low magnesium (hypomagnesemia), and elevated calcium (hypercalcemia). Symptoms include fatigue, palpitations, confusion, headache, or muscle weakness. Routine lab checks help detect and correct imbalances early.
Metabolic: Increased uric acid (possible gout flare), mild increases in blood glucose, and lipid changes. These effects are usually modest but warrant attention in at-risk individuals.
Dermatologic and photosensitivity: Sunburn-like reactions and rashes can occur; use sun protection. Rarely, serious skin reactions (such as Stevens–Johnson syndrome) can develop; seek care for widespread rash, blistering, or mucosal involvement.
Rare but serious: Pancreatitis, severe dehydration, acute kidney injury, blood dyscrasias (low white cells or platelets), and acute angle-closure glaucoma. If you notice severe abdominal pain, persistent vomiting, visual changes, marked weakness, fainting, or signs of infection or bleeding, seek urgent medical attention.
Lithium: Thiazides reduce lithium clearance, increasing the risk of lithium toxicity. Avoid the combination or monitor lithium levels closely with appropriate dose adjustments.
Dofetilide: Contraindicated with HCTZ due to increased dofetilide concentrations and risk of torsades de pointes (a life-threatening arrhythmia).
NSAIDs: Ibuprofen, naproxen, and similar agents can blunt HCTZ’s blood-pressure-lowering and diuretic effects and may increase kidney risk, especially in dehydrated or older patients.
Digoxin: Low potassium or magnesium from HCTZ increases digoxin toxicity risk. Monitor electrolytes and digoxin levels as indicated.
Corticosteroids and ACTH: May worsen hypokalemia; extra monitoring may be needed.
Bile acid sequestrants: Cholestyramine and colestipol can reduce HCTZ absorption. If used together, separate dosing (e.g., HCTZ at least 4–6 hours before or after).
Antidiabetic medications: Thiazides can raise blood glucose slightly; insulin or oral antidiabetic doses may require adjustment with closer monitoring.
Other antihypertensives, alcohol, and sedatives: Additive blood-pressure-lowering effects can increase dizziness or fainting—rise slowly and stay hydrated.
Additional considerations: Amphotericin B (hypokalemia), carbamazepine (hyponatremia), topiramate (metabolic acidosis/hypokalemia), cyclosporine (hyperuricemia/gout), and pressor amines (reduced response). Always share a complete medication and supplement list with your clinician.
If you miss a dose, take it when you remember unless it is late in the day or close to your next dose. Because HCTZ increases urination, taking it late may disrupt sleep. If it’s almost time for your next dose, skip the missed dose and resume your usual schedule. Do not double up. If you miss multiple doses or experience a blood pressure increase, contact your healthcare provider for guidance.
An overdose can lead to profound diuresis, dehydration, low blood pressure (dizziness, fainting), electrolyte imbalances (abnormal heart rhythms, weakness, confusion), and kidney injury. If an overdose is suspected, call your local emergency number or the Poison Help line (1-800-222-1222 in the U.S.) immediately. Do not induce vomiting unless instructed by a professional.
Treatment is supportive: airway and circulation support, intravenous fluids, and targeted correction of electrolytes. Activated charcoal may be considered if ingestion was recent. There is no specific antidote; hemodialysis is not expected to significantly enhance hydrochlorothiazide elimination.
Store hydrochlorothiazide at room temperature (68–77°F or 20–25°C), away from excessive heat, moisture, and light. Keep tablets in their original, tightly closed container with the desiccant if provided. Do not store in the bathroom. Keep out of reach of children and pets.
Do not use tablets past the expiration date. If your medication looks discolored, crumbled, or damaged, ask your pharmacist for a replacement. For disposal, use a medication take-back program; if unavailable, follow FDA or local guidelines. Never share prescription medicines with others.
In the United States, hydrochlorothiazide is an FDA-approved, prescription-only medication. Legitimate access requires an evaluation by a licensed clinician who determines that the medicine is appropriate for you and provides a valid prescription. Purchasing prescription drugs from sources that offer them “without a prescription” is unsafe and may be illegal; such sites frequently dispense counterfeit or substandard products and bypass essential safety checks.
Safe, legal options include in-person care or telehealth services where a qualified clinician reviews your history, current medications, and lab needs, then prescribes HCTZ when appropriate. After that, you can fill the prescription at an accredited, U.S.-licensed pharmacy (local or mail-order). Verify online pharmacies through .pharmacy domain or NABP accreditation and avoid vendors that do not require a prescription.
Geisinger HealthSouth provides a structured, compliant pathway to access care for conditions like hypertension. Through a telehealth visit or coordinated clinic care, licensed clinicians can assess your blood pressure control, order labs if needed, and, when appropriate, issue a valid prescription for hydrochlorothiazide that you can fill through trusted pharmacies. This approach preserves convenience—often without an in-person visit—while ensuring you receive the medication legally, with appropriate monitoring and follow-up.
Costs for hydrochlorothiazide are typically low, especially for generic tablets. Many insurance plans cover it with minimal copays. For those paying cash, discount programs and mail-order pharmacies can further reduce prices. Your care team can help you choose a reputable, licensed pharmacy and set up refills to maintain continuity of therapy.
Bottom line: do not attempt to buy hydrochlorothiazide without prescription. Instead, use legitimate clinical channels—such as telehealth or in-network care—to obtain an appropriate evaluation and a lawful prescription. This safeguards your health through correct dosing, interaction screening, and lab monitoring, while ensuring the medication’s quality and authenticity.
Hydrochlorothiazide is a thiazide diuretic (“water pill”) used to treat high blood pressure and fluid retention (edema) by helping your kidneys remove extra salt and water while relaxing blood vessels.
It blocks the sodium-chloride transporter in the kidney’s distal tubule, increasing salt and water excretion. Over time it reduces blood volume and decreases peripheral vascular resistance, which lowers blood pressure.
It is prescribed for hypertension, edema from heart failure, liver cirrhosis, or kidney disorders, and to help prevent calcium kidney stones in certain people by reducing urinary calcium.
Increased urination starts within 2 hours, peaks around 4–6 hours, and lasts 6–12 hours. Blood pressure improvement begins within days, with full effect often seen after 2–4 weeks of consistent use.
For hypertension, common doses are 12.5–25 mg once daily; some people may need 50 mg, though benefits often plateau while side effects rise. For edema, doses can be higher under medical supervision. Always follow your clinician’s instructions.
Frequent urination (especially initially), dizziness or lightheadedness, weakness, low potassium, low sodium, increased uric acid (gout flares), mild increases in blood sugar or cholesterol, and photosensitivity (sun sensitivity).
Severe dizziness or fainting, muscle cramps, extreme thirst, confusion, irregular heartbeat, signs of severe dehydration, eye pain or sudden vision changes (rare angle-closure glaucoma), severe rash, or gout attack. Seek medical care if these occur.
Yes, it can lower potassium by increasing urinary loss. Your clinician may recommend dietary potassium, a potassium-sparing medication, or adjusting the dose. Never add supplements without medical advice, especially if you have kidney disease.
People with anuria (no urine output), severe kidney dysfunction where thiazides are ineffective, known hypersensitivity to hydrochlorothiazide, or a history of thiazide-induced severe hyponatremia should avoid it. Use caution with gout, diabetes, or significant electrolyte abnormalities.
Thiazides are less effective when eGFR is below about 30 mL/min/1.73 m². Your clinician may choose other diuretics or use a thiazide-like option such as metolazone in specific scenarios. Monitoring of electrolytes and kidney function is essential.
It can slightly raise blood glucose, uric acid, and LDL/triglycerides at higher doses. Effects are typically modest at low doses used for hypertension but can be clinically relevant in diabetes or gout.
Yes. It can increase sun sensitivity and, rarely, cause a photosensitive rash. Use sunscreen, protective clothing, and report persistent rashes. Very rare cases of non-melanoma skin cancer have been reported with long-term use; regular skin checks are prudent.
NSAIDs may blunt its blood pressure and diuretic effect. Lithium levels can rise to toxic levels. Other antihypertensives add to blood pressure lowering. Digoxin risk increases if potassium is low. Corticosteroids can worsen potassium loss. Discuss all medicines and supplements with your clinician.
Alcohol can enhance dizziness and low blood pressure; use cautiously. Regular NSAID use (ibuprofen, naproxen) can reduce hydrochlorothiazide’s effectiveness and stress the kidneys; limit and consult your clinician.
It is generally avoided in pregnancy because it can reduce plasma volume and may affect placental perfusion; safer alternatives are preferred. Small amounts pass into breast milk and may reduce milk supply; discuss risks and benefits if breastfeeding.
Check electrolytes (sodium, potassium), kidney function (creatinine, eGFR), uric acid, and in some cases glucose and lipids. Early checks are often done 1–2 weeks after starting or changing dose, then periodically.
Morning is preferred to reduce nighttime urination. If prescribed twice daily, take the second dose mid-afternoon. Keep timing consistent day to day.
Take it when you remember unless it’s close to the next dose. Do not double up. Resume your regular schedule and monitor for dizziness if doses are taken too close together.
Do not stop without guidance. Blood pressure may rebound and fluid can accumulate. Your clinician can taper or switch medications if needed.
Limit sodium, follow a DASH-style diet, maintain a healthy weight, exercise regularly, moderate alcohol, avoid smoking, and manage sleep and stress. These steps often enhance blood pressure control and reduce medication needs.
Chlorthalidone is longer-acting and generally lowers blood pressure more at equivalent doses, with stronger cardiovascular outcome data. However, it may cause more hyponatremia and hypokalemia. Hydrochlorothiazide is shorter-acting and often better tolerated.
Indapamide (thiazide-like) has a long duration and strong outcome data in hypertension, including in older adults. It may have a more favorable metabolic profile at low doses. Hydrochlorothiazide is widely available and effective but shorter-acting. Choice depends on patient factors and availability.
Metolazone is thiazide-like and uniquely effective even at lower eGFR, often used with loop diuretics for resistant edema in heart failure. It is potent and can cause profound electrolyte losses. Hydrochlorothiazide is preferred for routine hypertension; metolazone is reserved for refractory fluid overload.
Because chlorthalidone lasts 24–72 hours, it tends to provide steadier around-the-clock control, including night-time blood pressure. Hydrochlorothiazide’s effect wanes sooner, which may be less effective for nocturnal hypertension in some patients.
Both are thiazide diuretics used for hypertension and edema. Bendroflumethiazide is commonly used in some countries at low doses (e.g., 2.5 mg). Efficacy and side effects are broadly similar; availability and local guidelines often drive selection.
Hydrochlorothiazide is more potent and longer-acting by mouth and is the usual choice. Chlorothiazide has an intravenous form used in select inpatient scenarios. For chronic outpatient therapy, hydrochlorothiazide is generally preferred.
Chlorthalidone tends to cause more hyponatremia and hypokalemia due to its longer and stronger effect. Careful dosing and monitoring can mitigate risks. Hydrochlorothiazide has a somewhat lower risk but still requires monitoring.
Indapamide at low doses may have slightly less impact on glucose and lipids, and trials have shown good cardiovascular outcomes in diabetes. Hydrochlorothiazide can be used safely at low doses with monitoring. Individual response and comorbidities guide the choice.
For eGFR above ~30, hydrochlorothiazide works well. Below that, thiazides lose potency; metolazone can remain effective and is often paired with loop diuretics for edema. Close monitoring for dehydration and electrolyte disturbances is essential with metolazone.
Some evidence suggests thiazide-like agents (chlorthalidone, indapamide) reduce cardiovascular events more than hydrochlorothiazide at comparable blood pressure reductions, likely due to longer duration. However, they may have more electrolyte side effects.
Low-dose chlorthalidone or indapamide often provide robust control, but older adults are more susceptible to hyponatremia, hypokalemia, and orthostatic hypotension. Hydrochlorothiazide may be better tolerated in some. Start low, go slow, and monitor labs and symptoms.
All thiazides can raise uric acid and trigger gout. Risk rises with higher doses and longer exposure. Comparative differences are small; chlorthalidone may raise uric acid more than hydrochlorothiazide. In gout-prone patients, consider alternative agents or urate-lowering therapy.
All thiazide and thiazide-like diuretics can reduce urinary calcium and help prevent calcium stones. Some clinicians favor chlorthalidone or indapamide for their longer action, but tolerability and electrolyte balance often determine the best choice.
No. Chlorthalidone is more potent and longer-acting. Roughly, chlorthalidone 12.5 mg is often similar to hydrochlorothiazide 25 mg, but conversions should be individualized with monitoring of blood pressure and electrolytes.